These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 39168550)

  • 1. Fibroadipose Vascular Anomaly: Diagnosis and Treatment.
    Shaikh R
    Tech Vasc Interv Radiol; 2024 Jun; 27(2):100961. PubMed ID: 39168550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryoablation in fibro-adipose vascular anomaly (FAVA): a minimally invasive treatment option.
    Shaikh R; Alomari AI; Kerr CL; Miller P; Spencer SA
    Pediatr Radiol; 2016 Jul; 46(8):1179-86. PubMed ID: 26902298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress about the fibro-adipose vascular anomaly: A review.
    Sun YR; Zou ML; Yuan SM
    Medicine (Baltimore); 2024 Feb; 103(7):e37225. PubMed ID: 38363925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibro-adipose vascular anomaly (FAVA) - diagnosis, staging and management.
    Wang H; Xie C; Lin W; Wang P; Yang W; Guo Z
    Orphanet J Rare Dis; 2023 Nov; 18(1):347. PubMed ID: 37936141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroadipose Vascular Anomaly in the Upper Extremity: A Distinct Entity With Characteristic Clinical, Radiological, and Histopathological Findings.
    Cheung K; Taghinia AH; Sood RF; Alomari AI; Spencer SA; Al-Ibraheemi A; Kozakewich HPW; Chaudry G; Greene AK; Mulliken JB; Trenor CC; Fishman SJ; Upton J
    J Hand Surg Am; 2020 Jan; 45(1):68.e1-68.e13. PubMed ID: 31279623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibro-adipose vascular anomaly (FAVA): three case reports with an emphasis on the mammalian target of rapamycin (mTOR) pathway.
    Hori Y; Hirose K; Aramaki-Hattori N; Suzuki S; Nakayama R; Inoue M; Matsui T; Kohara M; Toyosawa S; Morii E
    Diagn Pathol; 2020 Jul; 15(1):98. PubMed ID: 32711543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryoablation of low-flow vascular malformations.
    Ramaswamy RS; Tiwari T; Darcy MD; Kim SK; Akinwande O; Dasgupta N; Guevara CJ
    Diagn Interv Radiol; 2019 May; 25(3):225-230. PubMed ID: 31063139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful Treatment of Fibro-Adipose Vascular Anomaly with Sirolimus.
    Wang Z; Yan H; Ding Y; Gong Y; Ma Y; Yao W; Li K
    J Pediatr Surg; 2023 Jul; 58(7):1337-1341. PubMed ID: 36898877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and imaging features in fibro-adipose vascular anomaly (FAVA).
    Amarneh M; Shaikh R
    Pediatr Radiol; 2020 Mar; 50(3):380-387. PubMed ID: 31834427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Fibro-adipose Vascular Anomalies (FAVA) in Paediatric Practice.
    Lipede C; Nikkhah D; Ashton R; Murphy G; Barnacle AM; Patel PA; Smith GD; Eastwood DM; Sivakumar B
    JPRAS Open; 2021 Sep; 29():71-81. PubMed ID: 34189232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibro-adipose vascular anomaly: clinical-radiologic-pathologic features of a newly delineated disorder of the extremity.
    Alomari AI; Spencer SA; Arnold RW; Chaudry G; Kasser JR; Burrows PE; Govender P; Padua HM; Dillon B; Upton J; Taghinia AH; Fishman SJ; Mulliken JB; Fevurly RD; Greene AK; Landrigan-Ossar M; Paltiel HJ; Trenor CC; Kozakewich HP
    J Pediatr Orthop; 2014 Jan; 34(1):109-17. PubMed ID: 24322574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Venous Malformations: The Data, Where We Are, and How It Is Done.
    Hage AN; Chick JFB; Srinivasa RN; Bundy JJ; Chauhan NR; Acord M; Gemmete JJ
    Tech Vasc Interv Radiol; 2018 Jun; 21(2):45-54. PubMed ID: 29784122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibro-Adipose Vascular Anomaly: Characteristic Imaging Features on Sonography and Magnetic Resonance Imaging.
    Hu W; Gong Y; Ma J; Wu G
    Vasc Endovascular Surg; 2023 Feb; 57(2):106-113. PubMed ID: 36168791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibro-Adipose Vascular Anomaly (FAVA): Not Another Vascular Anagram.
    Barwad A; Narwal A; Dutta R; Behera R; Kumar VS; Rastogi S; Mridha AR
    Int J Surg Pathol; 2023 Jul; ():10668969231188419. PubMed ID: 37461272
    [No Abstract]   [Full Text] [Related]  

  • 15. Surgical Management of Fibroadipose Vascular Anomaly of the Lower Extremities.
    Wang KK; Glenn RL; Adams DM; Alomari AI; Al-Ibraheemi A; Anderson ME; Chaudry G; Fishman SJ; Greene AK; Shaikh R; Trenor CC; Kozakewich HP; Spencer SA
    J Pediatr Orthop; 2020 Mar; 40(3):e227-e236. PubMed ID: 31181028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroadipose vascular anomaly treated with sirolimus: Successful outcome in two patients.
    Erickson J; McAuliffe W; Blennerhassett L; Halbert A
    Pediatr Dermatol; 2017 Nov; 34(6):e317-e320. PubMed ID: 29144050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous Sclerotherapy of Venous Malformations.
    Kim KR
    Tech Vasc Interv Radiol; 2024 Jun; 27(2):100960. PubMed ID: 39168545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower Extremity Fibro-Adipose Vascular Anomaly: A Post-surgical Rehabilitation Treatment.
    Cunha M; Gonçalves F; Almeida G; Azevedo MJ; Cunha J
    Cureus; 2024 Jun; 16(6):e62708. PubMed ID: 39036281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PIK3CA mutation correlates with mTOR pathway expression but not clinical and pathological features in Fibfibroipose vascular anomaly (FAVA).
    Hori Y; Hirose K; Ozeki M; Hata K; Motooka D; Tahara S; Matsui T; Kohara M; Higashihara H; Ono Y; Tanaka K; Toyosawa S; Morii E
    Diagn Pathol; 2022 Jan; 17(1):19. PubMed ID: 35094709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of foam sclerotherapy for treatment of low-flow vascular malformations in children.
    Markovic JN; Nag U; Shortell CK
    J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):1074-1082. PubMed ID: 32284312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.